drugset
drugset / Trial / NCT03824912

Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea Pedis

NCT03824912 ↗

Phase 3 Completed 831 enrolled Encube Ethicals Pvt. Ltd. ACM Global Laboratories · collabNovum Pharmaceutical Research Services · collab
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea Pedis

Timeline

Start
2018-08-23
Primary completion
2019-01-24
Completion
2019-01-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketoconazole Small molecule 2 % Topical

Indications

tinea pedis